Financing round-up: RedHill Biopharma, Fosanis, Redcliffe Lifetech, Germitec, Imagene AI

Israel: Imagene AI, an emerging AI-based developer of medicine for cancer, has raised US$21.5m, comprising US$3m in seed funding led by Blumberg Capital and an US$18.5m Series A round led by Larry Ellison, Dr David Agus, and AI imaging space pioneer Eyal Gura. Using only a digitized biopsy image, Imagene’s AI diagnostic technology delivers real-time…

You must be a HMI Subscriber to view this content.

Subscribe Now »